Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of Boston Scientific Corporation (NYSE: BSX) failed to manage Boston Scientific in an acceptable manner, breaching their fiduciary duties to Boston Scientific, and whether Boston Scientific and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know:

• On February 4, 2026, Boston Scientific announced disappointing sales in its EP segment. On this news, Boston Scientific stock dropped 17.6%.
• If you own Boston Scientific common stock, join our investigation on behalf of Boston Scientific and its shareholders by filling out the form here.

If you own Boston Scientific common stock and you wish to discuss this investigation—at no cost for you—please contact attorney Joe Pettigrew toll-free at (844) 818-6982 or jpettigrew@scott-scott.com.

About this investigation – FAQ:

Q1: What is this ongoing investigation into Boston Scientific about?

A: According to our investigation, owners of Boston Scientific common stock have been impacted by massive potential civil liability and reputational damage against Boston Scientific from material misstatements and omissions to investors.

Q2: How does this Scott+Scott investigation work?

A: Joining our investigation is easy and at no cost for you. By filling out the form here, we will let you know your rights as a Boston Scientific shareholder, and how the process works and what you can expect. If you currently own Boston Scientific stock, we look forward to hearing from you.

To learn more about Scott+Scott, our attorneys, or complex case resolution, please visit www.scott-scott.com.

Attorney Advertising

View source version on businesswire.com: https://www.businesswire.com/news/home/20261022773398/en/

Scott+Scott Attorneys at Law LLP, an international securities and consumer rights litigation firm, is investigating whether the directors and officers of Boston Scientific (NYSE: BSX) breached their fiduciary duties to the Company and its shareholders.